| Monoclonal Gammopathy of Undetermined Significance studied in …STUDIED_INderived59 of 59show fewer |
|---|
| → studied in | NCT04920084NA · active not recruiting A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139476completed Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05831358NA · active not recruiting Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472830enrolling by invitation MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644625recruiting CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140524Phase 2 · recruiting A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06083922Phase 2 · recruiting A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Renal Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684274not yet recruiting Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06559033recruiting Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624760NA · not yet recruiting Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731844Phase 2 · completed Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269592recruiting Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07446777NA · recruiting FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214324recruiting Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02726750recruiting Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640843NA · recruiting A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383143recruiting Promoting Diagnosis and Management of AL in Italy (ProDigALIty) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136807recruiting Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361694recruiting Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408225recruiting Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969821not yet recruiting Clonal Hematopoiesis of Immunological Significance · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07448779recruiting Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04850846Phase 2 · active not recruiting Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01237054Phase 2 · completed Imaging in MGUS, SMM and MM · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07305662NA · not yet recruiting Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05065554Phase 2 · active not recruiting ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy · condition mapped CURATED_BROADER · 59 trials mapped (34 active) | — | — | IgM Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06237803recruiting European Myeloma Network (EMN) Sample Project · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055894NA · recruiting A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04114084recruiting Sleep Apnea in Patients With MGUS and MM · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03327597NA · active not recruiting Iceland Screens, Treats or Prevents Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565638NA · completed PROFAST Intervention in Precursor Multiple Myeloma · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03951220completed The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895291recruiting Whole Body MRI in Oncology · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06690593recruiting Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615572completed Screening to Improve Survival in AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02298816withdrawn B-Cell Hematologic Malignancy Vaccination Registry · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06418477Phase 2 · recruiting Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Renal Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06539832recruiting Intestinal Flora and Immunity in Monoclonal Gammopathy Patients · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03119883NA · completed Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04439006Phase 1 · completed Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05965115recruiting The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05114109Phase 2 · unknown Isatuximab in Type I Cryoglobulinemia · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05047107unknown Biology and Genetics of Smouldering Myeloma · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727294unknown MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01079429terminated Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109407terminated Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702932not yet recruiting Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01571726Phase 2 · withdrawn Imaging Studies and the Development of Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02566265Phase 2 · completed Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients · condition mapped ALIAS · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955395NA · completed Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00099047Phase 2 · completed Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00900263completed S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma · condition mapped PROBABILISTIC · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919139completed S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01219010Phase 1 · completed A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588822Phase 2 · terminated Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899353Phase 2 · terminated Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 59 trials mapped (34 active) | — | — | Monoclonal Gammopathy of Undetermined Significance | 1 | Observed | clinicaltrials | graph → |